Ultragenyx Pharmaceutical Inc.RARENASDAQ
LOADING
|||
Switch Symbol:
Revenue Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year revenue growth rate
Latest
-3.94%
↓ 107% below average
Average (39q)
53.73%
Historical baseline
Range
High:1119.19%
Low:-100.00%
Volatility
2269.3%
High variability
| Period | Value |
|---|---|
| Q3 2025 | -3.94% |
| Q2 2025 | 19.53% |
| Q1 2025 | -15.52% |
| Q4 2024 | 18.20% |
| Q3 2024 | -5.12% |
| Q2 2024 | 35.09% |
| Q1 2024 | -14.57% |
| Q4 2023 | 29.92% |
| Q3 2023 | -9.47% |
| Q2 2023 | 7.77% |
| Q1 2023 | -2.76% |
| Q4 2022 | 13.94% |
| Q3 2022 | 1.52% |
| Q2 2022 | 11.77% |
| Q1 2022 | -4.14% |
| Q4 2021 | 2.13% |
| Q3 2021 | -6.13% |
| Q2 2021 | -12.50% |
| Q1 2021 | 8.58% |
| Q4 2020 | 12.36% |
| Q3 2020 | 32.02% |
| Q2 2020 | 69.96% |
| Q1 2020 | 2.01% |
| Q4 2019 | 37.96% |
| Q3 2019 | 6.84% |
| Q2 2019 | 32.89% |
| Q1 2019 | 11.75% |
| Q4 2018 | 38.24% |
| Q3 2018 | -8.06% |
| Q2 2018 | 19.83% |
| Q1 2018 | 342.29% |
| Q4 2017 | 1119.19% |
| Q3 2017 | 0.00% |
| Q2 2017 | 0.00% |
| Q1 2017 | -100.00% |
| Q4 2016 | -95.50% |
| Q3 2016 | 552.94% |
| Q2 2016 | 0.00% |
| Q1 2016 | 0.00% |
| Q4 2015 | 0.00% |